| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/18/2013 | WO2013106007A1 Genetic sample collection systems |
| 07/18/2013 | WO2013105827A2 Recombinant microorganism having improved putrescine producing ability and method for producing putrescine by using same |
| 07/18/2013 | WO2013105807A2 Novel synthesis-regulating srna and method for preparing same |
| 07/18/2013 | WO2013105802A2 Microorganisms of corynebacterium which can utilize xylose and method for producing l-lysine using same |
| 07/18/2013 | WO2013105801A1 Probe for typing chronic myelogenous leukemia fusion genotype, primer and method for using same |
| 07/18/2013 | WO2013105800A2 Microorganisms of escherichia coli having enhanced l-tryptophan production and method for producing l-tryptophan using same |
| 07/18/2013 | WO2013105775A1 Method for multiplex-detecting chronic myelogenous leukemia gene using cuttable probe |
| 07/18/2013 | WO2013105774A1 Method for detecting c-met gene using cuttable probe |
| 07/18/2013 | WO2013105679A1 Apparatus for amplifying nucleic acids comprising primer, method for manufacturing same, and method for amplifying nucleic acids using apparatus comprising primer for amplifying nucleic acids |
| 07/18/2013 | WO2013105030A1 Mutated cephalosporin hydroxylase and its application in deacetylcephalosporanic acid synthesis |
| 07/18/2013 | WO2013105022A2 Organic compositions to treat beta-catenin-related diseases |
| 07/18/2013 | WO2013104728A1 Novel pseudotyped lentiviral particles and their use in the in vitro targeted transduction of undifferentiated pluripotent human embryonic stem cells and induced pluripotent stem cells |
| 07/18/2013 | WO2013104686A1 Cellular high throughput encapsulation for screening or selection |
| 07/18/2013 | WO2013104648A1 Method to identify ligands for sigma-1 receptors |
| 07/18/2013 | WO2013104540A1 New c5a binding nucleic acids |
| 07/18/2013 | WO2013104539A1 Nucleic acids specifically binding cgrp |
| 07/18/2013 | WO2013104424A1 Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, dna fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application |
| 07/18/2013 | WO2013104131A1 Standardized reference gene for microrna and use thereof |
| 07/18/2013 | WO2013104103A1 Colorectal cancer diagnosis and indication marker |
| 07/18/2013 | WO2013104102A1 Breast cancer diagnosis and indication marker |
| 07/18/2013 | WO2013104026A1 Method for modulating plant root architecture |
| 07/18/2013 | WO2013075110A3 A novel eml4-alk variant: primers, probes, methods, and kits for the detection thereof |
| 07/18/2013 | WO2013071295A3 Transcript optimized expression enhancement for high-level production of proteins and protein domains |
| 07/18/2013 | WO2013070852A3 Compounds and compositions used to epigenetically transform cells and methods related thereto |
| 07/18/2013 | WO2013066442A3 Mammalian genes and gene products involved in infection |
| 07/18/2013 | WO2013060819A3 Transient expression vectors, preparation and uses thereof |
| 07/18/2013 | WO2013052237A3 Systems and methods for assay of bio-contaminants in water |
| 07/18/2013 | WO2013049356A3 Ho/ll canola with resistance to clubroot disease |
| 07/18/2013 | WO2013040517A3 IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING CotH |
| 07/18/2013 | WO2013040116A9 Methods and compositions for weed control |
| 07/18/2013 | WO2013023151A3 Compositions and methods for treating celiac sprue disease |
| 07/18/2013 | WO2012165737A9 Cell-penetrating fusion protein for regenerating or proliferating stem cell |
| 07/18/2013 | US20130185830 Method of meristem excision and transformation |
| 07/18/2013 | US20130185829 Kernel productivity of plants through the modulation of glutamine synthetase activity |
| 07/18/2013 | US20130185828 Methods for improving abiotic stress response |
| 07/18/2013 | US20130185827 Transgenic soybean plants and chromosomes |
| 07/18/2013 | US20130185826 Materials, systems, organisms, and methods for enhancing abiotic stress tolerance, increasing biomass, and/or altering lignin composition |
| 07/18/2013 | US20130185825 Use of a seed specific promoter to drive odp1 expression in cruciferous oilseed plants to increase oil content while maintaining normal germination |
| 07/18/2013 | US20130185824 Method of Increasing Resistance Against Soybean Rust in Transgenic Plants by ADR-1-Gene |
| 07/18/2013 | US20130185823 Mesoporous silica nanoparticle-mediated delivery of dna into arabidopsis root |
| 07/18/2013 | US20130185818 Method to trigger rna interference |
| 07/18/2013 | US20130184449 DNA Encoding a Plant Lipase, Transgenic Plants and a Method for Controlling Senescence in Plants |
| 07/18/2013 | US20130184448 Modified ethylenediamine-n, n'-disuccinate: ethylenediamine lyase |
| 07/18/2013 | US20130184438 Mutant protein |
| 07/18/2013 | US20130184333 Growth factor isoform |
| 07/18/2013 | US20130184329 Compositions and methods for inhibiting expression of mutant egfr gene |
| 07/18/2013 | US20130184327 Cell growth inhibitor and screening method thereof |
| 07/18/2013 | US20130184326 Compositions and methods for inhibiting expression of factor vii gene |
| 07/18/2013 | US20130184325 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 07/18/2013 | US20130184324 Dual Targeting siRNA Agents |
| 07/18/2013 | US20130184220 Treatment of abnormal or excessive scars |
| 07/18/2013 | US20130184171 Multiplexed amplification of short nucleic acids |
| 07/18/2013 | US20130184165 Genotyping by next-generation sequencing |
| 07/18/2013 | US20130184160 Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof |
| 07/18/2013 | US20130183761 Methods for Incorporating Unnatural Amino Acids in Eukaryotic Cells |
| 07/18/2013 | US20130183760 Vectors for directional cloning |
| 07/18/2013 | US20130183759 Method of efficiently establishing induced pluripotent stem cells |
| 07/18/2013 | US20130183758 Host cells with artificial endosymbionts |
| 07/18/2013 | US20130183757 Method of efficiently establishing induced pluripotent stem cells |
| 07/18/2013 | US20130183754 NUCLEIC ACID CONSTRUCT CONTAINING A NUCLEIC ACID DERIVED FROM THE GENOME OF HEPATITIS C VIRUS (HCV) OF GENOTYPE 2a, AND A CELL HAVING SUCH NUCLEIC ACID CONSTRUCT INTRODUCED THEREIN |
| 07/18/2013 | US20130183743 Microbial Fuel Cell |
| 07/18/2013 | US20130183738 Transgenic plants modified for reduced cadmium transport, derivative products, and related methods |
| 07/18/2013 | US20130183719 Method for producing virus vector |
| 07/18/2013 | US20130183716 Novel glucose dehydrogenase |
| 07/18/2013 | US20130183713 Polypeptides Having Beta-Glucosidase Activity, Beta-Xylosidase Activity, or Beta-Glucosidase Activity and Beta-Xylosidase Activity And Polynucleotides Encoding Same |
| 07/18/2013 | US20130183431 Lettuce variety 41-26 rz, "reverte rz" |
| 07/18/2013 | US20130183430 Lettuce variety 81-97 rz, louxal rz |
| 07/18/2013 | US20130183347 Somatic Transgene Immunization and Related Methods |
| 07/18/2013 | US20130183339 Methods and compositions involving immunostimulatory oligodeoxynucleotides |
| 07/18/2013 | US20130183335 Recombinant modified vaccinia virus ankara influenza vaccine |
| 07/18/2013 | US20130183333 Induced activation in dendritic cells |
| 07/18/2013 | US20130183324 Immunogens for treatment of neoplastic and infectious disease |
| 07/18/2013 | US20130183319 Fgfr4 antibodies |
| 07/18/2013 | US20130183318 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 07/18/2013 | US20130183271 Methods and Compositions Concerning Poxviruses and Cancer |
| 07/18/2013 | CA2860974A1 A microorganism of the genus escherichia having enhanced l-tryptophan productivity and a method for producing l-tryptophan using the same |
| 07/18/2013 | CA2860864A1 Method for modulating plant root architecture |
| 07/18/2013 | CA2860852A1 Cellular high throughput encapsulation for screening or selection |
| 07/17/2013 | EP2615455A1 Translation and construction of non-standard peptide compound library containing n-methyl amino acids and other non-standard amino acids, and method for searching for active species |
| 07/17/2013 | EP2615179A2 Novel biological detection method for dioxins in serum, and a diagnostic use therefor in metabolic syndrome and related conditions |
| 07/17/2013 | EP2615176A1 Novel pseudotyped lentiviral particles and their use in the in vitro targeted transduction of undifferentiated pluripotent human embryonic stem cells and induced pluripotent stem cells |
| 07/17/2013 | EP2615175A1 Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals |
| 07/17/2013 | EP2615174A2 Plants having enhanced yield-related traits and/or increased abiotic stress resistance, and a method for making the same |
| 07/17/2013 | EP2615173A1 Insect resistant cotton plants and methods for identifying same |
| 07/17/2013 | EP2615172A1 Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| 07/17/2013 | EP2615171A1 Method for inhibiting nucleic acid amplification using light and highly sensitive method for selective nucleic acid amplification |
| 07/17/2013 | EP2615170A1 Coryneform bacterium transformant and method for producing phenol using same |
| 07/17/2013 | EP2615169A1 Flavin enzyme having flavonol 8-hydroxylase activity and use thereof |
| 07/17/2013 | EP2615168A1 Process for producing reveromycin a or a synthetic intermediate thereof, process for producing compounds containing a spiroketal ring and novel antineoplastics, fungicides and therapeutic agents for bone disorders |
| 07/17/2013 | EP2615164A1 Hyperphotosynthetic organisms |
| 07/17/2013 | EP2615163A1 Composition for preventing inflammations |
| 07/17/2013 | EP2615115A2 Antigen-binding constructs |
| 07/17/2013 | EP2615112A2 Purified immunoglobulin fusion proteins and methods of their purification |
| 07/17/2013 | EP2615111A1 Method to identify ligands for sigma-1 receptors |
| 07/17/2013 | EP2615107A1 A novel biopolymer having excellent tensile strength, extensibility and toughness |
| 07/17/2013 | EP2615104A1 Hepatitis c virus liposome vaccine |
| 07/17/2013 | EP2615102A1 Promoter inducible by reactive oxygen species and vector comprising the same |
| 07/17/2013 | EP2614836A2 High growth reassortant influenza A virus |
| 07/17/2013 | EP2614158A2 Predicting responses to androgen deprivation therapy |
| 07/17/2013 | EP2614157A2 Compositions and methods for nucleic acid based diagnostic assays for variable sequence targets |